Compare GPMT & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | RPTX |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.8M | 92.4M |
| IPO Year | 2017 | 2020 |
| Metric | GPMT | RPTX |
|---|---|---|
| Price | $2.54 | $2.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $3.13 | $3.00 |
| AVG Volume (30 Days) | 156.5K | ★ 808.3K |
| Earning Date | 11-05-2025 | 11-14-2025 |
| Dividend Yield | ★ 7.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,870,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21.74 | $9.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.61 | $0.89 |
| 52 Week High | $3.32 | $2.30 |
| Indicator | GPMT | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 58.37 |
| Support Level | $2.48 | $2.11 |
| Resistance Level | $2.82 | $2.27 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 13.89 | 47.06 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.